Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.
de Bruin RC, Stam AG, Vangone A, van Bergen En Henegouwen PM, Verheul HM, Sebestyén Z, Kuball J, Bonvin AM, de Gruijl TD, van der Vliet HJ. de Bruin RC, et al. Among authors: van der vliet hj, van bergen en henegouwen pm. J Immunol. 2017 Jan 1;198(1):308-317. doi: 10.4049/jimmunol.1600948. Epub 2016 Nov 28. J Immunol. 2017. PMID: 27895170
Case 19-2009: Carcinoma of the gastroesophageal junction.
van der Vliet HJ, van der Peet DL, Verheul HM. van der Vliet HJ, et al. Among authors: van der peet dl. N Engl J Med. 2009 Sep 24;361(13):1315; author reply 1315-6. doi: 10.1056/NEJMc091434. N Engl J Med. 2009. PMID: 19776417 No abstract available.
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.
Schneiders FL, Scheper RJ, von Blomberg BM, Woltman AM, Janssen HL, van den Eertwegh AJ, Verheul HM, de Gruijl TD, van der Vliet HJ. Schneiders FL, et al. Among authors: van der vliet hj, van den eertwegh aj. Clin Immunol. 2011 Aug;140(2):130-41. doi: 10.1016/j.clim.2010.11.010. Epub 2010 Dec 18. Clin Immunol. 2011. PMID: 21169066 Review.
Breast-cancer adjuvant therapy with zoledronic acid.
van der Vliet HJ, Verheul HM. van der Vliet HJ, et al. N Engl J Med. 2012 Jan 12;366(2):188-9; author reply 189. doi: 10.1056/NEJMc1113049. N Engl J Med. 2012. PMID: 22236236 Free article. No abstract available.
Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up.
Schneiders FL, de Bruin RC, van den Eertwegh AJ, Scheper RJ, Leemans CR, Brakenhoff RH, Langendijk JA, Verheul HM, de Gruijl TD, Molling JW, van der Vliet HJ. Schneiders FL, et al. Among authors: van der vliet hj, van den eertwegh aj. J Clin Oncol. 2012 Feb 10;30(5):567-70. doi: 10.1200/JCO.2011.38.8819. Epub 2012 Jan 17. J Clin Oncol. 2012. PMID: 22253469 No abstract available.
160 results